Literature DB >> 28405796

Antiphospholipid antibodies: crossroads between autoimmunity and infections?

Savino Sciascia1,2, Massimo Radin3, Mario Bazzan4, Dario Roccatello3,5.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28405796     DOI： 10.1007/s11739-017-1664-2

Source DB:  PubMed          Journal:  Intern Emerg Med        ISSN： 1828-0447            Impact factor:   3.397


× No keyword cloud information.
  5 in total

1.  Disappearance of antiphospholipid antibodies syndrome after Helicobacter pylori eradication.

Authors:  V Cicconi; E Carloni; F Franceschi; R Nocente; N G Silveri; R Manna; S Servidei; A R Bentivoglio; A Gasbarrini; G Gasbarrini
Journal:  Am J Med       Date:  2001-08       Impact factor: 4.965

Review 2.  Novel diagnostic and therapeutic frontiers in thrombotic anti-phospholipid syndrome.

Authors:  Savino Sciascia; Massimo Radin; Mario Bazzan; Dario Roccatello
Journal:  Intern Emerg Med       Date:  2017-01-02       Impact factor: 3.397

3.  Anti-phospholipid syndrome therapy.

Authors:  Antonio Ponzetto; Natale Figura; Andrea Caccioppo
Journal:  Intern Emerg Med       Date:  2017-02-10       Impact factor: 3.397

Review 4.  Antiphospholipid antibodies disappearance in primary antiphospholipid syndrome: Thrombosis recurrence.

Authors:  Gabriela Medina; Eduardo Briones-García; María Pilar Cruz-Domínguez; Oscar I Flórez-Durante; Luis J Jara
Journal:  Autoimmun Rev       Date:  2017-02-13       Impact factor: 9.754

Review 5.  Infections and vaccines in the etiology of antiphospholipid syndrome.

Authors:  Paola Cruz-Tapias; Miri Blank; Juan-Manuel Anaya; Yehuda Shoenfeld
Journal:  Curr Opin Rheumatol       Date:  2012-07       Impact factor: 5.006
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.